50
Participants
Start Date
February 23, 2024
Primary Completion Date
August 30, 2025
Study Completion Date
December 30, 2025
TR128
TR128 will be given daily for 28 days in 28-day cycles until there appears evidence of progressive disease, intolerable toxicity, or the subject discontinues from the study treatment for other reasons. Starting dose is 100mg, with escalation to 500mg.
RECRUITING
Beijing Cancer Hospital, Beijing
RECRUITING
Harbin Medical University Cancer Hospital, Harbin
RECRUITING
Tianjin Medical University Cancer Institute&Hospital, Tianjin
Tarapeutics Science Inc.
INDUSTRY